apothecary house 1 east street, rye, sussex, TN31 7JY
Website
-
apothecary developments ltdEstimated Valuation
£293k
Pomanda estimates the enterprise value of APOTHECARY DEVELOPMENTS LTD at £293k based on a Turnover of £891.8k and 0.33x industry multiple (adjusted for size and gross margin).
apothecary developments ltdEstimated Valuation
£69k
Pomanda estimates the enterprise value of APOTHECARY DEVELOPMENTS LTD at £69k based on an EBITDA of £26.6k and a 2.6x industry multiple (adjusted for size and gross margin).
apothecary developments ltdEstimated Valuation
£150.1k
Pomanda estimates the enterprise value of APOTHECARY DEVELOPMENTS LTD at £150.1k based on Net Assets of £106.2k and 1.41x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Apothecary Developments LtdOverview
Apothecary Developments Ltd is a live company located in sussex, TN31 7JY with a Companies House number of 12931903. It operates in the development of building projects sector, SIC Code 41100. Founded in October 2020, it's largest shareholder is
trevor esdaile
with a 50% stake. Apothecary Developments Ltd is a young,
small sized company, Pomanda has estimated its turnover at
£891.8k with
rapid
growth in recent years.
Pomanda's financial health check has awarded Apothecary Developments Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
4 Strong
1 Regular
5 Weak
Size
annual sales of £891.8k, make it smaller than the average company (£2.5m)
£891.8k - Apothecary Developments Ltd
£2.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 95%, show it is growing at a faster rate (7.1%)
95% - Apothecary Developments Ltd
7.1% - Industry AVG
Production
with a gross margin of 9.5%, this company has a higher cost of product (26.6%)
9.5% - Apothecary Developments Ltd
26.6% - Industry AVG
Profitability
an operating margin of 3% make it less profitable than the average company (7.4%)
3% - Apothecary Developments Ltd
7.4% - Industry AVG
Employees
with 2 employees, this is below the industry average (7)
2 - Apothecary Developments Ltd
7 - Industry AVG
Pay Structure
on an average salary of £49.8k, the company has an equivalent pay structure (£49.8k)
£49.8k - Apothecary Developments Ltd
£49.8k - Industry AVG
Efficiency
resulting in sales per employee of £445.9k, this is more efficient (£287.6k)
£445.9k - Apothecary Developments Ltd
£287.6k - Industry AVG
Debtor Days
it gets paid by customers after 121 days, this is later than average (29 days)
121 days - Apothecary Developments Ltd
29 days - Industry AVG
Creditor Days
its suppliers are paid after 81 days, this is slower than average (32 days)
81 days - Apothecary Developments Ltd
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Apothecary Developments Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Apothecary Developments Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 64.3%, this is a lower level of debt than the average (73.4%)
64.3% - Apothecary Developments Ltd
73.4% - Industry AVG
APOTHECARY DEVELOPMENTS LTD financials
EXPORT
Apothecary Developments Ltd's latest turnover from October 2024 is estimated at £891.8 thousand and the company has net assets of £106.2 thousand. According to their latest financial statements, Apothecary Developments Ltd has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Oct 2024
Oct 2023
Oct 2022
Oct 2021
Turnover
891,783
18,119
17,442
119,821
Other Income Or Grants
Cost Of Sales
807,387
16,347
15,722
109,230
Gross Profit
84,396
1,772
1,720
10,591
Admin Expenses
57,839
-5,241
-6,606
-80,451
Operating Profit
26,557
7,013
8,326
91,042
Interest Payable
Interest Receivable
27
Pre-Tax Profit
26,557
6,567
9,034
91,069
Tax
-6,639
-1,307
-1,796
-17,303
Profit After Tax
19,918
5,260
7,238
73,766
Dividends Paid
Retained Profit
19,918
5,260
7,238
73,766
Employee Costs
99,664
87,740
Number Of Employees
2
2
2
2
EBITDA*
26,557
7,325
8,743
91,597
* Earnings Before Interest, Tax, Depreciation and Amortisation
Oct 2024
Oct 2023
Oct 2022
Oct 2021
Tangible Assets
125,000
125,000
116,667
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
125,000
125,000
116,667
Stock & work in progress
21,447
Trade Debtors
297,402
22,514
42,175
Group Debtors
55,577
Misc Debtors
1,441
204
Cash
54,200
misc current assets
total current assets
297,402
22,514
43,616
131,428
total assets
297,402
147,514
168,616
248,095
Bank overdraft
Bank loan
Trade Creditors
179,568
55,998
87,137
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
174,279
total current liabilities
179,568
55,998
87,137
174,279
loans
hp & lease commitments
Accruals and Deferred Income
11,600
other liabilities
provisions
5,200
425
total long term liabilities
11,600
5,200
425
total liabilities
191,168
61,198
87,562
174,279
net assets
106,234
86,316
81,054
73,816
total shareholders funds
106,234
86,316
81,054
73,816
Oct 2024
Oct 2023
Oct 2022
Oct 2021
Operating Activities
Operating Profit
26,557
7,013
8,326
91,042
Depreciation
312
417
555
Amortisation
Tax
-6,639
-1,307
-1,796
-17,303
Stock
-21,447
21,447
Debtors
274,888
-21,102
-12,165
55,781
Creditors
123,570
-31,139
87,137
Accruals and Deferred Income
11,600
-174,279
174,279
Deferred Taxes & Provisions
-5,200
4,775
425
Cash flow from operations
-125,000
756
-46,158
171,345
Investing Activities
capital expenditure
125,000
-312
-8,750
-117,222
Change in Investments
cash flow from investments
125,000
-312
-8,750
-117,222
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
2
50
interest
27
cash flow from financing
2
77
cash and cash equivalents
cash
-54,200
54,200
overdraft
change in cash
-54,200
54,200
apothecary developments ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for apothecary developments ltd. Get real-time insights into apothecary developments ltd's credit score, group structure and payment trends.
Perform a competitor analysis for apothecary developments ltd by selecting its closest rivals, whether from the CONSTRUCTION sector, other small companies, companies in TN31 area or any other competitors across 12 key performance metrics.
apothecary developments ltd Ownership
APOTHECARY DEVELOPMENTS LTD group structure
Apothecary Developments Ltd has no subsidiary companies.
Ultimate parent company
APOTHECARY DEVELOPMENTS LTD
12931903
APOTHECARY DEVELOPMENTS LTD Shareholders
The largest shareholders in Apothecary Developments Ltd include Trevor Esdaile and Steve Fasey.
trevor esdaile
50%
steve fasey
50%
apothecary developments ltd directors
Apothecary Developments Ltd currently has 2 directors.
The longest serving directors include
Mr Trevor Esdaile (Oct 2020) and
Mr Steve Fasey (Oct 2020).
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
October 2024
net assets
106.2k
+0.23%
total assets
297.4k
+1.02%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
Similar companies unavailable for this selection
apothecary developments ltd company details
company number
12931903
Type
Private limited with Share Capital
industry
41100 - Development of building projects
incorporation date
October 2020
age
5
incorporated
UK
ultimate parent company
None
accounts
Micro-Entity Accounts
last accounts submitted
October 2024
previous names
N/A
accountant
-
auditor
-
address
apothecary house 1 east street, rye, sussex, TN31 7JY
Bank
-
Legal Advisor
-
apothecary developments ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to apothecary developments ltd.
apothecary developments ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for APOTHECARY DEVELOPMENTS LTD. This can take several minutes, an email will notify you when this has completed.
apothecary developments ltdCompanies House Filings - See Documents
